Insurance companies generally cover Ozempic and Wegovy when it is prescribed for Type-2 diabetes. However, when the drugs are ...

As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the ...

Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, during a session on India Today Conclave 2025, said that many celebrities may not want to admit to taking Ozempic ...

Vikrant Shrotriya, Novo Nordisk India's Managing Director, addressed concerns over the side effects of Ozempic during a ...

The medical director of a Denver eating disorder clinic says popular medications that are being used as weight loss drugs are ...

Vikrant Shrotriya, Managing Director of Novo Nordisk India, said that Ozempic is not a 'party drug' but works with diet and ...

With more diners skipping mains, drinking less and sharing starters because of weight-loss drugs, the traditional ...

Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...

Exclusive: Vikrant Shrotriya, Corporate Vice President & Managing Director, Novo Nordisk India, has warned that the ‘wonder drug’ Ozemic is not a ‘party drug’. In a special conversation with Kalli ...

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

WHEN doctors told her she was overweight, former Big Brother star Narinder Kaur took a decision that could have claimed her ...

FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...